SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-317485
Filing Date
2019-12-18
Accepted
2019-12-18 16:01:12
Documents
13
Period of Report
2019-12-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d807113d8k.htm   iXBRL 8-K 35878
2 EX-99.1 d807113dex991.htm EX-99.1 1320404
  Complete submission text file 0001193125-19-317485.txt   1791037

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hznp-20191218.xsd EX-101.SCH 3086
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20191218_lab.xml EX-101.LAB 18841
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20191218_pre.xml EX-101.PRE 11850
7 EXTRACTED XBRL INSTANCE DOCUMENT d807113d8k_htm.xml XML 3599
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 191292537
SIC: 2834 Pharmaceutical Preparations